Flash and pattern visual evoked potentials were recorded in 8 patients (13 eyes) with dysthyroid optic neuropathy (DON), diagnosed using the American Thyroid Associ ation classification. All were treated with systemic ster oids, but 4 patients (6 eyes) also required orbital decompression. Flash YEP (P2) and pattern YEP (PI00) were recorded prior to and 2 weeks after commencing steroid treatment or decompression. Fifteen patients with Graves orbitopathy but without DON, and 20 healthy subjects, acted as controls. Before treatment visual acuity was reduced in 10 eyes and visual fields were abnormal in 5, but the YEP was abnormal in all 13, with the group mean amplitude of P2 and PI00 significantly less than controls, and the group mean PIOO latency significantly greater than controls. After treatment with high-dose steroids or surgical decompression there were significant improvements in the group mean amplitude of P2 and PIOO, and significant reductions in P2 and PIOO latency; however, individually, improvements in amplitude were more significant than improvements in latency. We con clude that the YEP to flash and pattern stimuli provides a useful diagnostic and monitoring tool in patients with DON, combining objectivity with quantitative analysis.
Thyroid optic neuropathy is a serious although infrequent (5-8%)1 . 2 complication of Graves orbitopathy requiring urgent management to avoid severe visual loss. I The diag nosis of dysthyroid optic neuropathy (DON) can be based on a variety of clinical features including decrease in visual acuity, visual field and colour vision abnormalities, optic disc changes or the presence of an afferent pupillary defect.3 However, as previous authors have shown, orbital changes and visual symptoms can be variable and incon sistent, and the patient may be unaware of visual loss until advanced clinical changes have occurred. 1,35 Furthermore, the presence of DON may be subclinical, and masked by the more obvious signs of orbital congestion. 2, 4 Correspondence to: Dr P. A, Good, Visual Function Department, Birmingham and Midland Eye Hospital, Church Street, Birmingham B3 2NS, UK.
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Although CT scanning will identify the severity of apical crowding, and therefore identify those at risk of DON,2,3,4,6 Neigel et al. 2 suggest that once the clinician is alerted 'appropriate psychophysical and electrophysio logic testing should be carried out' . These tests may include colour vision analysis (FII OO or Ishihara), visual fields (Goldmann perimetry), pattern visual evoked poten tials (VEP), and pattern ERG (PERG). In Neigel et al.'s study" of 58 patients with DON, 64% had abnormal colour vision, 66% had abnormal fields, whilst the pattern YEP was abnormal in 94%.
Other authors also support the use of the YEP as a sensi tive indicator of optic nerve dysfunction in Graves orbito pathy.8-IO Furthermore Boback et al.11 have advocated the use of steady-state pattern YAP recordings in thyroid disease, and studies by Setala et al.6,9 have identified changes in the waveform as well as the latency of the flash YEP in DON. However, recent work by Potts et al.1 2 and Fells 13 supports the usefulness of colour contrast sensitiv ity along the tritan blue axis in preference to pattern YEP and PERG, and Suttorp-Schulten et al. 14 describe disturb ances in luminance contrast sensitivity in a high percent age of patients with thyroid eye disease.
Various treatment regimes are advocated for the management of DON ;7,13 therefore, not only is early diag nosis important, but the response to any one form of treat ment needs to be carefully monitored as patients not responding, or relapsing, after one treatment regime may respond to another. 1,4 There is clearly a need to have avail able an objective method to aid in both the diagnosis and monitoring of DON. This study aims to show the value of the flash and pattern YEP in the diagnosis of DON and the monitoring of patients' response to treatment.
PATIENTS AND METHODS
We reviewed the clinical presentation and the VEPs in all patients (n = 8) diagnosed and treated for DON at this centre in the past 7 years. Five patients had bilateral DON and 3 had only unilateral involvement. All 8 patients (age range 26-73 years, mean age 49.1 years) (13 eyes) ful filled the classification of the American Thyroid Associ ation.ls All patients had been diagnosed on the basis of CT scan abnormalities, in addition to at least one of the fol lowing: a reduction in Snellen visual acuity of > 2 lines (10 eyes), field loss (5 eyes), afferent pupillary defect (APD) (3 eyes), or swollen discs (2 eyes). In addition 2 patients had unilateral exposure-related corneal pathology as well as an APD.
All patients were treated with systemic steroids, and 4 patients (6 eyes) also underwent surgical decompression.
VEPs had been recorded on all patients before and after treatment. The VEPs in the DON group were compared with those recorded in two control groups. One group con sisted of 15 patients (age range 23-68 years, mean age 45.1 years) with Graves orbitopathy but no clinical evi dence of DON (who represented all patients seen over the same time period as the DON group who had more than one YEP performed, and who were clinically euthyroid at the time of recording). These 15 patients were from a group of 84 patients with Graves orbitopathy but no clini cal evidence of DON who underwent YEP investigation between 1986 and 1993. The other control group consisted of 20 randomly selected healthy subjects (age range 22-68 years, mean age 46.1 years) with no clinical evidence of neurological abnormality or ophthalmic disease. In the DON group there were 5 women and 3 men, and in the Graves orbitopathy without DON group there were 10 women and 5 men. In the normal control group there were 12 women and 8 men.
VEPs were performed to flash and pattern stimulation. The flash VEPs were obtained using a diffuse flash pro vided by a Grass photic stimulator producing a stimulus intensity of 2000 candela per metre (cd/m). Pattern VEPs were obtained using a black and white reversing chequer board stimulus (80% contrast, 85 cdlm luminance) sub tending 50' of arc at the subject' s eye at 50 cm. All recordings were transient using a stimulus rate of 2 Hz.
For the pattern YEP a check size of 50' was chosen as it is large enough to be seen by a patient with early lens or corneal opacities and yet still stimulates the central mag nocellular pathways, particularly ganglion receptor fields within the perifoveal region, the axons of which are more likely to be affected by orbital compression than axons from ganglion cells responding to smaller check stimuli.
Two recording channels were employed using silveri silver chloride electrodes placed over the occipital cortex 3 cm either side of the inion (01, 02) and referred to an electrode placed over the mid-frontal cortex (Fz) (refer ence positive). Recordings were made using either a Nic olet C4 or a Nicolet CAIOOO clinical averager, but in all cases the same equipment was used on each individual for consecutive recordings.
A pre-treatment flash and pattern YEP had been recorded in all patients with DON, and these VEPs were also recorded over a period of 2 weeks following com mencement of steroid treatment or orbital decompression. In 3 of the 6 patients treated with high-dose steroids the YEP was recorded every 2-4 days during the 2 weeks of treatment (see Fig. 1-4) .
The 6 patients (10 eyes) whose VEPs were monitored whilst they were on high-dose steroid treatment were receiving between 60 and 90 mg prednisolone daily throughout the 2 week period.
All 4 patients (6 eyes) who underwent orbital decom pression, were receiving < 10 mg prednisolone daily at the time of surgery, although 2 patients (3 eyes) had pre viously undergone high-dose steroid treatment. 4.7 In those patients with Graves orbitopathy, who acted as non-treatment controls, consecutive VEPs were analysed that had been recorded no more than 1 month apart.
Measurements were made of the peak-to-peak ampli tude and absolute latency of P2 (flash) and PIOO (pattern). As well as identifying individual changes in P2 and PI OO amplitude and latency after treatment, statistical compari son, using the paired t-test, was also made of the group mean amplitude and latency of P2 and PI OO between the recordings made before and after treatment, compared with the control groups. A further comparison was made between the group mean percentage improvement in the amplitude of the YEP after treatment in the steroid and decompression groups and the group mean percentage variation in amplitude in the Graves control group, which was the group mean percentage variation in amplitude between consecutive recordings. Similar comparisons of latency variation (in milliseconds) were also made.
RESULTS
Pre-treatment recordings revealed that there was a signifi cant reduction in group mean amplitude of P2 and PI OO components in the DON group compared with either con trol group (see Ta ble 1). The group mean latency of the P2 and PI OO components was also significantly longer in the DON group compared with controls. Eleven of the 13 eyes with DON exhibited PIOO amplitude reductions which were either relative (an interocular difference of > 25%) or absolute (a value <4IlV, which is the normal standard in this unit). Seven eyes had a delay of PI 00, but of these 4 eyes were relative delays only (interocular difference >8 ms, being beyond the upper limit of normal. Eight of the 13 eyes with DON exhibited a pre-treatment reduction in amplitude of the P2 component. Although the mean P2 latency improved after treatment, only 1 eye was beyond the normal range of P2 (> 130 ms).
A 'W' -shaped (negative PI 00) response to pattern was noted in 3 eyes (see Fig. 6 ). This waveform abnormality also resulted in a delay of PI 00 to > 120 ms, and was present in 2 patients, 1 of whom exhibited PI OO compon ents of normal amplitude in both eyes. One of the 3 patients with clinically unilateral DON had a reduction in the PIOO component in the presumed normal eye, but the other 2 patients had normal VEPs in their clinically normal eye.
Amongst the controls with Graves disease the group mean amplitude of P2 and PI 00 was not significantly dif ferent from the normal control group (see Ta ble I); how- 
Steroids
Of the 10 eyes with DON treated with high-dose systemic steroids, 7 exhibited a reduction in the amplitude of the pre-treatment PI OO components to <41lV (see Figs. 1-4 ). All 7 eyes improved to within normal limits of amplitude (>4 IlV), although there remained a significant inter ocular difference in 4 eyes. Three eyes had a delay of the pre-treatment PIOO component. In all 3 this was a delay to > 120 ms, induding the 1 patient (2 eyes) with a normal PI OO amplitude. In 1 eye the amplitude of PI00 was too low to measure the latency. In 3 eyes the latency recovered to normal values. The group mean improvement in PI 00 amplitude which correlated with a group mean percentage improvement of l03.S% was significantly greater (p<0.001) than the mean amplitude variation amongst the Graves control group (see Tables II and III) . The group mean latency in PIOO improvement was -4.7 ms, which was also a signifi cant (p <O.OS) improvement compared with the mean con trol (Graves group) variation.
Four eyes with DON in this treatment group also had a reduction in the amplitude of the pre-treatment P2 to <4 IlV, all of which improved to within normal limits (>4 IlV) after treatment with systemic steroids, although 2 eyes still exhibited a persistent interocular difference of >2S%. One other eye exhibited a compara tive reduction (> 2S%) in P2 amplitude, which recovered after treatment.
The group mean improvement in P2 amplitude, which correlated with a group mean percentage improvement of 73.8% (see Tables II and Ill) , was significant (p<O.OS) compared with the mean amplitude variation amongst the Graves control group. Although the pre-treatment P2 component was within normal limits of latency ( < 130 ms) in all but I eye, after treatment there was a sig- nificant reduction (p<0.01) (-S.I ms) in group mean latency compared with the Graves control group.
In comparing the worse affected eye with the less affected eye amongst those patients treated with high-dose systemic steroids the group mean percentage improve ment in P2 amplitude was 103% in the worse eye, and 9.7% in the better eye. For PI OO the group mean percent age improvement was 14S% in the worse eye and 44% in the better eye.
Decompression
Of the 6 eyes (4 patients) that were surgically decom pressed, 3 eyes (2 patients) had relapsed after their steroid dose had been reduced. The remaining 3 eyes were sur gically decompressed for progressive exophthalmos with concurent DON. None of the 6 eyes had received high dose systemic steroids4 . 7 within the month prior to decompression.
Five eyes showed a reduction in the amplitude of the PIOO component to <4 IlV pre-decompression, and P2 was reduced in 2 eyes (see Table I , and Figs. I-S). Fol lowing decompression surgery these amplitude reductions returned to normal in all but 1 eye which had concurrent severe corneal pathology, where only a recovery of P2 occurred. Following decompression the percentage group mean flash YEP amplitude increased by 167%, and the pattern YEP amplitude by 129% (see Table III ). This was significantly greater than the group mean percentage vari ation of the Graves control group (p<0.00l in either case) but was not significantly different from the percentage increase seen following steroid treatment.
The PI 00 component was delayed in 4 eyes and sub sequently improved after decompression. In I other eye the amplitude was so reduced as to make measurement of latency impossible. After decompression the PI OO returned to normal limits of amplitude and latency in all but 1 eye. No delays in P2 were noted.
Following decompression the group mean latency of the flash YEP was shortened by 3.3 ms, and the pattern YEP by lS.2 ms, which again was significantly less (p<O.OS to flash and p<O.OOl to pattern) than the group mean variance in latency exhibited by the Graves control group. The PI 00 latency differences were more significant (p<0.02S) than in the group treated with high-dose steroids (see Table I ). PATIENT W.J.
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DISCUSSION
The results of this retrospective study of the YEP in dys thyroid optic neuropathy have confirmed the finding of other authors2.16 that the YEP pattern stimulation is a sen sitive diagnostic indicator of optic nerve compression in this condition. However, it is notable that in our study reductions in pattern amplitude occurred more frequently than delays, whereas other authors have emphasised delay as the main feature of abnormality.8,16 A study of 33 patients with 'endocrine orbitopathy' by Wijngaarde and Yon Lith16 found that there was no significant reduction in group mean amplitude of responses to a 10 chequerboard stimulus, but delays in these responses were often seen. In studies by Setala et al. g,9 15 patients with DON were assessed using the flash YEP before and up to 7 years after orbital decompression. They found that before treatment there was a significant delay of the group mean major positive component, but only 5 eyes exhibited an ampli tude reduction. They also observed that at 6 months after surgery there were no significant improvements in ampli tude or latency. However, another study by Yan Lith et al. 17 on the effects of optic nerve compression on the pat tern YEP indicated that both amplitude reductions and delays do occur and the incidence of one or the other depends on the site and size of the lesion.
To our knowledge this is the first study to use a combi nation of flash and pattern YEP to identify optic nerve compression. As well as amplitude and latency changes we have also taken into account waveform abnormalities ('W' -shaped response; see of eyes. This phenomenon has been previously described by Setala et al., g,9 and most probably represents a mechan ical compressive or torsional effect on nerve fibres, result ing in some nerve fibres conducting differently to others within the same nerve in response to the same stimulus.
It was notable that taking into consideration all patients with DON there was a significant (108.8%) improvement in group mean P2 amplitude after treatment. This percent age improvement is similar to that seen to pattern stimuli (113.3%), suggesting that in monitoring terms the flash YEP is as sensitive as the pattern YEP. Furthermore, in those patients who had relapsed following a reduction in steroid treatment, and who therefore required surgical decompression, the YEP had deteriorated significantly to both flash and pattern stimuli at this time. Indeed, such reductions represented objective evidence of a need to carry out surgical decompression, and the deterioration in the YEP (particularly to flash) was one of the principal deciding factors for this option in clinical management, especially where clinical signs were obscured by corneal pathology.
The increases in YEP amplitude and reductions in latency were similar following treatment with systemic steroids or surgical decompression, although the reduc tion in PI 00 latency was more significant in the surgically decompressed group. However, this latter finding may be explained by the fact that the YEPs tended to be poorer in this group prior to surgery, thus making exact latency measurements more difficult.
There remains some debate concerning the value of the various psychophysical and electrophysiological tests in the diagnosis and monitoring of DON. More recently Potts et al. 12 and Fells" have cited the use of colour con trast sensitivity loss along the tritan axis as the most sensi tive indicator of increasing DON. The use of pattern stimulation in the YEP and PERG is limited by the influ ence of a number of factors many of which are unrelated to the disease process. Notable amongst these are opaque media, incorrect refraction, and poor patient compli ance, IX . 1 9 and psychophysical tests may also be limited by these factors. When considering improvements in the YEP after treat ment it is important to identify any factors unrelated to recovery of visual function as a potential cause for such improvements. Having established that the flash YEP is largely unaffected by factors not related to the functional state of the central visual pathways, it is nevertheless poss ible that the improvements in the YEP are merely a steroid effect unrelated to improvements in visual function. How ever, such a steroid effect would be expected to be equally distributed between the two eyes. This was clearly not the case since in patients treated with high-dose systemic steroids, the percentage improvement in the amplitude of the P2 component in the worse affected eye was more than 10 times that of the less affected eye, and for the PI 00 component this relative improvement was more than 3 times. Similarly, other factors which may affect YEP amplitude such as changes in background EEG activity must also be insignificant. It has also been reported2o.21 that changes in thyroid state alter the YEP, particularly in terms of latency. Seven of the 8 patients studied were euth yroid at the time of recording the YEP; therefore it is unlikely that this was a significant factor in providing the recorded improvements in the VEP.
The results of our study identify the use of the flash yEP as well as the pattern YEP as a robust and sensitive moni toring tool in cases of DON, particularly as the amplitude of the flash YEP is largely unaffected by the ocular media, refraction or compliance.22 Whilst in diagnostic terms reductions and delays in PIOO are more indicative of DON, the flash YEP would appear to be a useful addition to the pattern YEP, PERG and colour contrast sensitivity.
